A citation-based method for searching scientific literature

Rahel Zulliger, Shannon M Conley, Muna I Naash. J Control Release 2015
Times Cited: 29







List of co-cited articles
270 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Nanoparticle-based technologies for retinal gene therapy.
Jeffrey Adijanto, Muna I Naash. Eur J Pharm Biopharm 2015
46
27

Effect of gene therapy on visual function in Leber's congenital amaurosis.
James W B Bainbridge, Alexander J Smith, Susie S Barker, Scott Robbie, Robert Henderson, Kamaljit Balaggan, Ananth Viswanathan, Graham E Holder, Andrew Stockman, Nick Tyler,[...]. N Engl J Med 2008
24

Safety and efficacy of gene transfer for Leber's congenital amaurosis.
Albert M Maguire, Francesca Simonelli, Eric A Pierce, Edward N Pugh, Federico Mingozzi, Jeannette Bennicelli, Sandro Banfi, Kathleen A Marshall, Francesco Testa, Enrico M Surace,[...]. N Engl J Med 2008
24

Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial.
Robert E MacLaren, Markus Groppe, Alun R Barnard, Charles L Cottriall, Tanya Tolmachova, Len Seymour, K Reed Clark, Matthew J During, Frans P M Cremers, Graeme C M Black,[...]. Lancet 2014
522
20

Vector platforms for gene therapy of inherited retinopathies.
Ivana Trapani, Agostina Puppo, Alberto Auricchio. Prog Retin Eye Res 2014
88
20

The movement of self-assembled amphiphilic polymeric nanoparticles in the vitreous and retina after intravitreal injection.
Heebeom Koo, Hyungwon Moon, Hyounkoo Han, Jin Hee Na, Myung Sook Huh, Jae Hyung Park, Se Joon Woo, Kyu Hyung Park, Ick Chan Kwon, Kwangmeyung Kim,[...]. Biomaterials 2012
114
20

Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles.
Jean-Louis Bourges, Sandrine E Gautier, Florence Delie, Riad A Bejjani, Jean-Claude Jeanny, Robert Gurny, David BenEzra, Francine F Behar-Cohen. Invest Ophthalmol Vis Sci 2003
207
20

Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial.
William W Hauswirth, Tomas S Aleman, Shalesh Kaushal, Artur V Cideciyan, Sharon B Schwartz, Lili Wang, Thomas J Conlon, Sanford L Boye, Terence R Flotte, Barry J Byrne,[...]. Hum Gene Ther 2008
726
20

Let There Be Light: Gene and Cell Therapy for Blindness.
Deniz Dalkara, Olivier Goureau, Katia Marazova, José-Alain Sahel. Hum Gene Ther 2016
78
20

Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial.
Stephen Russell, Jean Bennett, Jennifer A Wellman, Daniel C Chung, Zi-Fan Yu, Amy Tillman, Janet Wittes, Julie Pappas, Okan Elci, Sarah McCague,[...]. Lancet 2017
725
20

In vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous.
Deniz Dalkara, Leah C Byrne, Ryan R Klimczak, Meike Visel, Lu Yin, William H Merigan, John G Flannery, David V Schaffer. Sci Transl Med 2013
401
17

Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement.
Artur V Cideciyan, Samuel G Jacobson, William A Beltran, Alexander Sumaroka, Malgorzata Swider, Simone Iwabe, Alejandro J Roman, Melani B Olivares, Sharon B Schwartz, András M Komáromy,[...]. Proc Natl Acad Sci U S A 2013
301
17

Vitreous: a barrier to nonviral ocular gene therapy.
Liesbeth Peeters, Niek N Sanders, Kevin Braeckmans, Koen Boussery, Johan Van de Voorde, Stefaan C De Smedt, Joseph Demeester. Invest Ophthalmol Vis Sci 2005
122
17

Coating nanocarriers with hyaluronic acid facilitates intravitreal drug delivery for retinal gene therapy.
Thomas F Martens, Katrien Remaut, Hendrik Deschout, Johan F J Engbersen, Wim E Hennink, Mies J van Steenbergen, Jo Demeester, Stefaan C De Smedt, Kevin Braeckmans. J Control Release 2015
88
17

Vitreous is a barrier in nonviral gene transfer by cationic lipids and polymers.
Leena Pitkänen, Marika Ruponen, Jenni Nieminen, Arto Urtti. Pharm Res 2003
85
17

Structural recovery of the retina in a retinoschisin-deficient mouse after gene replacement therapy by solid lipid nanoparticles.
P S Apaolaza, A Del Pozo-Rodríguez, M A Solinís, J M Rodríguez, U Friedrich, J Torrecilla, B H F Weber, A Rodríguez-Gascón. Biomaterials 2016
51
17

Viral-mediated RdCVF and RdCVFL expression protects cone and rod photoreceptors in retinal degeneration.
Leah C Byrne, Deniz Dalkara, Gabriel Luna, Steven K Fisher, Emmanuelle Clérin, Jose-Alain Sahel, Thierry Léveillard, John G Flannery. J Clin Invest 2015
108
17

Persistence of non-viral vector mediated RPE65 expression: case for viability as a gene transfer therapy for RPE-based diseases.
Adarsha Koirala, Shannon M Conley, Rasha Makkia, Zhao Liu, Mark J Cooper, Janet R Sparrow, Muna I Naash. J Control Release 2013
25
16

Drug and gene delivery to the back of the eye: from bench to bedside.
Cheryl L Rowe-Rendleman, Shelley A Durazo, Uday B Kompella, Kay D Rittenhouse, Adriana Di Polo, Alan L Weiner, Hans E Grossniklaus, Muna I Naash, Alfred S Lewin, Alan Horsager,[...]. Invest Ophthalmol Vis Sci 2014
75
13

CNTF Gene Therapy Confers Lifelong Neuroprotection in a Mouse Model of Human Retinitis Pigmentosa.
Daniel M Lipinski, Alun R Barnard, Mandeep S Singh, Chris Martin, Edward J Lee, Wayne I L Davies, Robert E MacLaren. Mol Ther 2015
49
13

Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial.
Jean Bennett, Jennifer Wellman, Kathleen A Marshall, Sarah McCague, Manzar Ashtari, Julie DiStefano-Pappas, Okan U Elci, Daniel C Chung, Junwei Sun, J Fraser Wright,[...]. Lancet 2016
261
13

Transduction of photoreceptors with equine infectious anemia virus lentiviral vectors: safety and biodistribution of StarGen for Stargardt disease.
Katie Binley, Peter Widdowson, Julie Loader, Michelle Kelleher, Sharifah Iqball, Georgina Ferrige, Jackie de Belin, Marie Carlucci, Diana Angell-Manning, Felicity Hurst,[...]. Invest Ophthalmol Vis Sci 2013
79
13

Improvement and decline in vision with gene therapy in childhood blindness.
Samuel G Jacobson, Artur V Cideciyan, Alejandro J Roman, Alexander Sumaroka, Sharon B Schwartz, Elise Heon, William W Hauswirth. N Engl J Med 2015
243
13

Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous.
Deniz Dalkara, Kathleen D Kolstad, Natalia Caporale, Meike Visel, Ryan R Klimczak, David V Schaffer, John G Flannery. Mol Ther 2009
192
13

Hyaluronan-modified core-shell liponanoparticles targeting CD44-positive retinal pigment epithelium cells via intravitreal injection.
Li Gan, Jing Wang, Yanan Zhao, Dan Chen, Chunliu Zhu, Jianping Liu, Yong Gan. Biomaterials 2013
58
13

Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo.
Qingguo Xu, Nicholas J Boylan, Jung Soo Suk, Ying-Ying Wang, Elizabeth A Nance, Jeh-Chang Yang, Peter J McDonnell, Richard A Cone, Elia J Duh, Justin Hanes. J Control Release 2013
155
13


Measuring the intravitreal mobility of nanomedicines with single-particle tracking microscopy.
Thomas F Martens, Dries Vercauteren, Katrien Forier, Hendrik Deschout, Katrien Remaut, Rik Paesen, Marcel Ameloot, Johan Fj Engbersen, Jo Demeester, Stefaan C De Smedt,[...]. Nanomedicine (Lond) 2013
51
13

RPGR-associated retinopathy: clinical features, molecular genetics, animal models and therapeutic options.
James J L Tee, Alexander J Smith, Alison J Hardcastle, Michel Michaelides. Br J Ophthalmol 2016
50
13

In Vivo CRISPR/Cas9 Gene Editing Corrects Retinal Dystrophy in the S334ter-3 Rat Model of Autosomal Dominant Retinitis Pigmentosa.
Benjamin Bakondi, Wenjian Lv, Bin Lu, Melissa K Jones, Yuchun Tsai, Kevin J Kim, Rachelle Levy, Aslam Abbasi Akhtar, Joshua J Breunig, Clive N Svendsen,[...]. Mol Ther 2016
189
13

Plasmid size up to 20 kbp does not limit effective in vivo lung gene transfer using compacted DNA nanoparticles.
T L Fink, P J Klepcyk, S M Oette, C R Gedeon, S L Hyatt, T H Kowalczyk, R C Moen, M J Cooper. Gene Ther 2006
99
13

Suppression and replacement gene therapy for autosomal dominant disease in a murine model of dominant retinitis pigmentosa.
Sophia Millington-Ward, Naomi Chadderton, Mary O'Reilly, Arpad Palfi, Tobias Goldmann, Claire Kilty, Marian Humphries, Uwe Wolfrum, Jean Bennett, Peter Humphries,[...]. Mol Ther 2011
105
13

Gene therapy restores vision in a canine model of childhood blindness.
G M Acland, G D Aguirre, J Ray, Q Zhang, T S Aleman, A V Cideciyan, S E Pearce-Kelling, V Anand, Y Zeng, A M Maguire,[...]. Nat Genet 2001
862
13

DNA nanoparticle-mediated ABCA4 delivery rescues Stargardt dystrophy in mice.
Zongchao Han, Shannon M Conley, Rasha S Makkia, Mark J Cooper, Muna I Naash. J Clin Invest 2012
101
13

Genomic DNA nanoparticles rescue rhodopsin-associated retinitis pigmentosa phenotype.
Zongchao Han, Marcellus J Banworth, Rasha Makkia, Shannon M Conley, Muayyad R Al-Ubaidi, Mark J Cooper, Muna I Naash. FASEB J 2015
32
13

Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach.
F M Mowat, K R Gornik, A Dinculescu, S L Boye, W W Hauswirth, S M Petersen-Jones, J T Bartoe. Gene Ther 2014
74
13

Changes in adeno-associated virus-mediated gene delivery in retinal degeneration.
Kathleen D Kolstad, Deniz Dalkara, Karen Guerin, Meike Visel, Natalie Hoffmann, David V Schaffer, John G Flannery. Hum Gene Ther 2010
49
13

Toward smart design of retinal drug carriers: a novel bovine retinal explant model to study the barrier role of the vitreoretinal interface.
Karen Peynshaert, Joke Devoldere, Valérie Forster, Serge Picaud, Christian Vanhove, Stefaan C De Smedt, Katrien Remaut. Drug Deliv 2017
25
16

S/MAR-containing DNA nanoparticles promote persistent RPE gene expression and improvement in RPE65-associated LCA.
Adarsha Koirala, Rasha S Makkia, Shannon M Conley, Mark J Cooper, Muna I Naash. Hum Mol Genet 2013
51
13

Efficient non-viral ocular gene transfer with compacted DNA nanoparticles.
Rafal Farjo, Jeff Skaggs, Alexander B Quiambao, Mark J Cooper, Muna I Naash. PLoS One 2006
146
10


Gene therapy clinical trials worldwide to 2012 - an update.
Samantha L Ginn, Ian E Alexander, Michael L Edelstein, Mohammad R Abedi, Jo Wixon. J Gene Med 2013
473
10

Improved retinal function in a mouse model of dominant retinitis pigmentosa following AAV-delivered gene therapy.
Naomi Chadderton, Sophia Millington-Ward, Arpad Palfi, Mary O'Reilly, Gearóid Tuohy, Marian M Humphries, Tiansen Li, Peter Humphries, Paul F Kenna, G Jane Farrar. Mol Ther 2009
96
10

Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies.
Steven D Schwartz, Carl D Regillo, Byron L Lam, Dean Eliott, Philip J Rosenfeld, Ninel Z Gregori, Jean-Pierre Hubschman, Janet L Davis, Gad Heilwell, Marc Spirn,[...]. Lancet 2015
720
10

Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial.
Albert M Maguire, Katherine A High, Alberto Auricchio, J Fraser Wright, Eric A Pierce, Francesco Testa, Federico Mingozzi, Jeannette L Bennicelli, Gui-shuang Ying, Settimio Rossi,[...]. Lancet 2009
592
10

Reversal of end-stage retinal degeneration and restoration of visual function by photoreceptor transplantation.
Mandeep S Singh, Peter Charbel Issa, Rachel Butler, Chris Martin, Daniel M Lipinski, Sumathi Sekaran, Alun R Barnard, Robert E MacLaren. Proc Natl Acad Sci U S A 2013
164
10

Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa.
F Q Liang, T S Aleman, N S Dejneka, L Dudus, K J Fisher, A M Maguire, S G Jacobson, J Bennett. Mol Ther 2001
180
10

Visual Acuity after Retinal Gene Therapy for Choroideremia.
Thomas L Edwards, Jasleen K Jolly, Markus Groppe, Alun R Barnard, Charles L Cottriall, Tanya Tolmachova, Graeme C Black, Andrew R Webster, Andrew J Lotery, Graham E Holder,[...]. N Engl J Med 2016
144
10

Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years.
Samuel G Jacobson, Artur V Cideciyan, Ramakrishna Ratnakaram, Elise Heon, Sharon B Schwartz, Alejandro J Roman, Marc C Peden, Tomas S Aleman, Sanford L Boye, Alexander Sumaroka,[...]. Arch Ophthalmol 2012
440
10

Long-term suppression of ocular neovascularization by intraocular injection of biodegradable polymeric particles containing a serpin-derived peptide.
Ron B Shmueli, Masayuki Ohnaka, Akiko Miki, Niranjan B Pandey, Raquel Lima e Silva, Jacob E Koskimaki, Jayoung Kim, Aleksander S Popel, Peter A Campochiaro, Jordan J Green. Biomaterials 2013
40
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.